Qiao Y Bobo

FDA Investigator Report

Designation: Regulatory Officer

Duty Station: Silver Spring MD 20993-0002

Organizations: DHHS FDA CBER CBER OCBQ DMPQ BII

Total Inspections: 10

Total 483s Issued: 10

Total Warning Letters Issued: 0

Inspection Details

Longest Inspection: 9 days

Shortest Inspection: 5 days

Average Length of Inspection: 3.6 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Recent Inspections

DateCompanyCityCountryFEI Number483
2024-01-26Hainan Shuangcheng Pharmaceuticals Co LtdHainanshengChina3009010397
2024-01-16Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)LianyungangChina3007373503
2015-12-11Abraham J. and Phyllis Katz Cord Blood FoundationWarrensville HeightsUnited States3006718574
2014-05-06Ipsen Biopharm Ltd.WrexhamUnited Kingdom1000346340
2014-03-07Rentschler Biopharma Inc.MilfordUnited States3003282293
2012-07-25Takeda Manufacturing Italia SPACittaducaleItaly3007244131
2011-10-07Organogenesis, Inc.CantonUnited States1000148471
2011-05-05SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)DresdenGermany3004835618
2010-11-12Ortho Clinical Diagnostics IncRaritanUnited States2250051
2010-06-24Maxim Biomedical Inc.RockvilleUnited States1122236

Sign Up to get the complete report.

Download 483s and EIRs for Qiao Y Bobo

Co-Inspectors

NameInspectionsLast Inspection
Arsen Karapetyan22024
Chad R Burger12015
Michele L Forster12015
Jie He12014
Jeremy L Wally12014
Rebecca K Olin12011
Gang Wang12011
Joseph D Doleski12010
Nicole K Trudel12010
Lori P Peters12010
Marion Michaelis12010

Active Locations

Year-wise Inspection Count